Show simple item record

dc.contributor.authorKeld, Richard
dc.contributor.authorGuo, Baoqiang
dc.contributor.authorDowney, Paul
dc.contributor.authorGulmann, Christian
dc.contributor.authorAng, Yeng S
dc.contributor.authorSharrocks, Andrew D
dc.date.accessioned2011-01-26T16:58:33Z
dc.date.available2011-01-26T16:58:33Z
dc.date.issued2010-12-09
dc.identifier.issnhttp://dx.doi.org/10.1186/1476-4598-9-313
dc.identifier.urihttp://hdl.handle.net/10147/120428
dc.description.abstractAbstract Background Many members of the ETS-domain transcription factor family are important drivers of tumourigenesis. In this context, their activation by Ras-ERK pathway signaling is particularly relevant to the tumourigenic properties of many ETS-domain transcription factors. The PEA3 subfamily of ETS-domain transcription factors have been implicated in tumour metastasis in several different cancers. Results Here, we have studied the expression of the PEA3 subfamily members PEA3/ETV4 and ER81/ETV1 in oesophageal adenocarcinomas and determined their role in oesophageal adenocarcinoma cell function. PEA3 plays an important role in controlling both the proliferation and invasive properties of OE33 oesophageal adenocarcinoma cells. A key target gene is MMP-1. The ERK MAP kinase pathway activates PEA3 subfamily members and also plays a role in these PEA3 controlled events, establishing the ERK-PEA3-MMP-1 axis as important in OE33 cells. PEA3 subfamily members are upregulated in human adenocarcinomas and expression correlates with MMP-1 expression and late stage metastatic disease. Enhanced ERK signaling is also more prevalent in late stage oesophageal adenocarcinomas. Conclusions This study shows that the ERK-PEA3-MMP-1 axis is upregulated in oesophageal adenocarcinoma cells and is a potentially important driver of the metastatic progression of oesophageal adenocarcinomas.
dc.language.isoenen
dc.subjectOESOPHAGEAL CANCERen
dc.subjectGENETICSen
dc.titleThe ERK MAP kinase-PEA3/ETV4-MMP-1 axis is operative in oesophageal adenocarcinomaen
dc.typeArticleen
dc.language.rfc3066en
dc.rights.holderKeld et al.; licensee BioMed Central Ltd.
dc.description.statusPeer Reviewed
dc.date.updated2010-12-23T18:01:25Z
refterms.dateFOA2018-08-22T10:31:42Z
html.description.abstractAbstract Background Many members of the ETS-domain transcription factor family are important drivers of tumourigenesis. In this context, their activation by Ras-ERK pathway signaling is particularly relevant to the tumourigenic properties of many ETS-domain transcription factors. The PEA3 subfamily of ETS-domain transcription factors have been implicated in tumour metastasis in several different cancers. Results Here, we have studied the expression of the PEA3 subfamily members PEA3/ETV4 and ER81/ETV1 in oesophageal adenocarcinomas and determined their role in oesophageal adenocarcinoma cell function. PEA3 plays an important role in controlling both the proliferation and invasive properties of OE33 oesophageal adenocarcinoma cells. A key target gene is MMP-1. The ERK MAP kinase pathway activates PEA3 subfamily members and also plays a role in these PEA3 controlled events, establishing the ERK-PEA3-MMP-1 axis as important in OE33 cells. PEA3 subfamily members are upregulated in human adenocarcinomas and expression correlates with MMP-1 expression and late stage metastatic disease. Enhanced ERK signaling is also more prevalent in late stage oesophageal adenocarcinomas. Conclusions This study shows that the ERK-PEA3-MMP-1 axis is upregulated in oesophageal adenocarcinoma cells and is a potentially important driver of the metastatic progression of oesophageal adenocarcinomas.


Files in this item

Thumbnail
Name:
1476-4598-9-313.xml
Size:
86.77Kb
Format:
XML
Thumbnail
Name:
1476-4598-9-313-S1.PDF
Size:
0bytes
Format:
PDF
Thumbnail
Name:
1476-4598-9-313.pdf
Size:
1.079Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record